Summary:
A 24-week study to evaluate the efficacy and safety of GSK573719/GW642444 inhalation powder in subjects with chronic obstructive pulmonary disease.
Qualified Participants Must:
• Be an outpatient
•
Be 40 years of age or older
•
Have COPD
•
Be a current or former cigarette smoker
•
Have shortness of breath
Qualified Participants May Receive:
All study-related medications, all study-related medical care at no cost, and compensation for time and travel.